Literature DB >> 30039195

Ascites IL-10 Promotes Ovarian Cancer Cell Migration.

Denis Lane1, Isabelle Matte1, Perrine Garde-Granger2, Paul Bessette3, Alain Piché4.   

Abstract

Ovarian cancer (OC) ascites is an inflammatory and immunosuppressive tumor environment characterized by the presence of various cytokines, chemokines and growth factors. The presence of high concentrations of these cytokines/chemokines in ascites is associated with a more aggressive tumor phenotype. IL-10 is an immunosuppressive cytokine for which high expression has been associated with poor prognosis in some cancers. However, its role on OC tumor cells has not been explored. Therefore, the aim of the current study was to elucidate the role of ascites IL-10 on the proliferation, migration and survival of OC cell lines. Here, we show that IL-10 levels are markedly increased in patients with advanced serous OC ascites relative to serous stage I/II ascites and peritoneal effusions from women with benign conditions. Ascites and IL-10 dose-dependently enhanced the proliferation and migration of OC cell lines CaOV3 and OVCAR3 but had no effect on cell survival. IL-10 levels in ascites positively correlated with the ability of ascites to promote cell migration but not proliferation. Depletion of IL-10 from ascites markedly inhibited ascites-induced OC cell migration but was not crucial for ascites-mediated cell proliferation. Taken together, our findings establish an important role for IL-10, as a component of ascites, in the migration of tumor cells.

Entities:  

Keywords:  Ascites; Cell migration; Cell proliferation; IL-10; Ovarian carcinoma

Year:  2018        PMID: 30039195      PMCID: PMC6250615          DOI: 10.1007/s12307-018-0215-3

Source DB:  PubMed          Journal:  Cancer Microenviron        ISSN: 1875-2284


  55 in total

Review 1.  IL-10 production by CD4+ effector T cells: a mechanism for self-regulation.

Authors:  D Jankovic; D G Kugler; A Sher
Journal:  Mucosal Immunol       Date:  2010-03-03       Impact factor: 7.313

2.  Fibronectin promotes migration and invasion of ovarian cancer cells through up-regulation of FAK-PI3K/Akt pathway.

Authors:  Nasser Ghaly Yousif
Journal:  Cell Biol Int       Date:  2013-10-17       Impact factor: 3.612

Review 3.  Biology of interleukin-10.

Authors:  Robert Sabat; Gerald Grütz; Katarzyna Warszawska; Stefan Kirsch; Ellen Witte; Kerstin Wolk; Jens Geginat
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-05       Impact factor: 7.638

4.  IL-10 promotes tumor aggressiveness via upregulation of CIP2A transcription in lung adenocarcinoma.

Authors:  Wen-Wei Sung; Yao-Chen Wang; Po-Lin Lin; Ya-Wen Cheng; Chih-Yi Chen; Tzu-Chin Wu; Huei Lee
Journal:  Clin Cancer Res       Date:  2013-06-06       Impact factor: 12.531

5.  Ovarian cancer ascites protects from TRAIL-induced cell death through alphavbeta5 integrin-mediated focal adhesion kinase and Akt activation.

Authors:  D Lane; N Goncharenko-Khaider; C Rancourt; A Piché
Journal:  Oncogene       Date:  2010-04-19       Impact factor: 9.867

6.  TLR4 signaling pathway in mouse Lewis lung cancer cells promotes the expression of TGF-β1 and IL-10 and tumor cells migration.

Authors:  Chun Li; Haixia Li; Kun Jiang; Jing Li; Xiaodong Gai
Journal:  Biomed Mater Eng       Date:  2014       Impact factor: 1.300

7.  The expression of interleukin-10 in patients with primary ovarian epithelial carcinoma and in ovarian carcinoma cell lines.

Authors:  J Zhou; F Ye; H Chen; W Lv; N Gan
Journal:  J Int Med Res       Date:  2007 May-Jun       Impact factor: 1.671

8.  Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma.

Authors:  Q Chen; V Daniel; D W Maher; P Hersey
Journal:  Int J Cancer       Date:  1994-03-01       Impact factor: 7.396

9.  Interleukin 10 production by human melanoma.

Authors:  T Sato; P McCue; K Masuoka; S Salwen; E C Lattime; M J Mastrangelo; D Berd
Journal:  Clin Cancer Res       Date:  1996-08       Impact factor: 12.531

10.  Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis.

Authors:  Nadzeya Goncharenko-Khaider; Isabelle Matte; Denis Lane; Claudine Rancourt; Alain Piché
Journal:  Mol Cancer       Date:  2012-11-17       Impact factor: 27.401

View more
  4 in total

Review 1.  IL-10 Signaling in the Tumor Microenvironment of Ovarian Cancer.

Authors:  Ramesh B Batchu; Oksana V Gruzdyn; Bala K Kolli; Rajesh Dachepalli; Prem S Umar; Sameer K Rai; Namrata Singh; Pavan S Tavva; Donald W Weaver; Scott A Gruber
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Extracellular Vesicles from Human Advanced-Stage Prostate Cancer Cells Modify the Inflammatory Response of Microenvironment-Residing Cells.

Authors:  Letizia Mezzasoma; Egidia Costanzi; Paolo Scarpelli; Vincenzo Nicola Talesa; Ilaria Bellezza
Journal:  Cancers (Basel)       Date:  2019-08-30       Impact factor: 6.639

Review 3.  Naturally Killing the Silent Killer: NK Cell-Based Immunotherapy for Ovarian Cancer.

Authors:  Sarah Nersesian; Haley Glazebrook; Jay Toulany; Stephanie R Grantham; Jeanette E Boudreau
Journal:  Front Immunol       Date:  2019-08-09       Impact factor: 7.561

4.  Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine.

Authors:  Mahmoud Mohammad Yaseen; Nizar Mohammad Abuharfeil; Homa Darmani; Ammar Daoud
Journal:  Open Biol       Date:  2020-09-16       Impact factor: 6.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.